How much revenue does Isodiol International make?

Isodiol International reported 22.25 million CAD in revenue for fiscal year 2019, up 16.3% from 19.14 million CAD in fiscal year 2018. In Q3 2020 revenue was 1.32 million CAD.

What companies are similar to Isodiol International?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Interpharm Holdings, Inc. (IPAH), OWC Pharmaceutical Research Corp. (OWCP), Arno Therapeutics, Inc. (ARNI), Flower One Holdings Inc. (FLOOF).

Isodiol International Inc. (ISOLF) Stock

About Isodiol International Inc.

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt pa...

At a glance

Isodiol International reported revenue of 22.25 million CAD for fiscal year 2019, up 16.3% from fiscal year 2018, and net income of -125.91 million CAD. In Q3 2020 (the quarter ended December 31, 2019) revenue was 1.32 million CAD, down 85.7% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2019.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.